Stock 4540 TSUMURA & CO.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tsumura & Co.

Equities

4540

JP3535800001

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 11:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
3,755 JPY +1.49% Intraday chart for Tsumura & Co. -0.58% +41.35%
06/02 Tsumura & Co. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
2023 Tsumura & Co. Provides Consolidated Earnings Guidance for the First Half Ending September 30, 2023 and Full Year Ending March 31, 2024 CI

Business Summary

TSUMURA & CO. is a Japan-based company mainly engaged in the manufacture and sale of ethical and general pharmaceuticals. Through its subsidiaries, the Company is also engaged in the procurement, sorting and processing of crude drugs, the manufacture and sale of Chinese herbal extract powders and drug substances, the operation of dispensing pharmacies and the provision of logistics services, as well as the development of pharmaceuticals.

Number of employees: 4,032

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
129,546 100.0 % 140,043 100.0 % +8.10%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
89.0 %
129,546 100.0 % 124,684 89.0 % -3.75%
Overseas
11.0 %
0 0.0 % 15,359 11.0 % -

Managers

Managers TitleAgeSince
Terukazu Kato CEO
 Chief Executive Officer 60 01/86/01
Muneki Handa DFI
 Director of Finance/CFO 61 01/19/01
Akito Imada CTO
 Chief Tech/Sci/R&D Officer - -
Hiroshi Hoshi CMP
 Compliance Officer - -
Shin Adachi COO
 Chief Operating Officer 61 01/87/01
Kimikazu Okochi BRD
 Director/Board Member 65 01/81/01
Ichiro Shingu IRC
 Investor Relations Contact - -
Yukinori Sorada SAM
 Sales & Marketing - -
Shuji Sugawara HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Kenichi Matsui BRD
 Director/Board Member 74 01/15/01
Hiroshi Miyake BRD
 Director/Board Member 74 01/18/01
Terukazu Kato CEO
 Chief Executive Officer 60 01/86/01
Tadashi Okada BRD
 Director/Board Member 67 01/20/01
Kimikazu Okochi BRD
 Director/Board Member 65 01/81/01
Muneki Handa DFI
 Director of Finance/CFO 61 01/19/01
Shin Adachi COO
 Chief Operating Officer 61 01/87/01
Mitsutoshi Matsushita BRD
 Director/Board Member 53 01/17/01
Akemi Mochizuki BRD
 Director/Board Member 69 01/19/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 76,758,362 69,217,297 ( 90.18 %) 830,841 ( 1.082 %) 90.18 %

Shareholders

NameEquities%Valuation
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.
9.999 %
7,675,000 9.999 % 194 M ¥
Invesco Asset Management (Japan) Ltd.
7.598 %
5,832,300 7.598 % 147 M ¥
Marathon Asset Management Ltd.
7.288 %
5,594,100 7.288 % 141 M ¥
MITSUBISHI UFJ FINANCIAL GROUP, INC
3.514 %
2,697,000 3.514 % 68 M ¥
Tsumura & Co. Employee Stock Ownership Plan
2.276 %
1,747,000 2.276 % 44 M ¥
Bright Ride Ltd.
2.204 %
1,692,000 2.204 % 43 M ¥
Nikko Asset Management Co., Ltd.
1.223 %
938,800 1.223 % 24 M ¥
MEDIPAL HOLDINGS CORPORATION
1.100 %
844,183 1.100 % 21 M ¥
ALFRESA HOLDINGS CORPORATION
0.9255 %
710,371 0.9255 % 18 M ¥
SUZUKEN CO., LTD.
0.8882 %
681,800 0.8882 % 17 M ¥

Holdings

NameEquities%Valuation
TOHO HOLDINGS CO., LTD.
1.22%
 934,060 1.22% 22,539,148 $
MEDIPAL HOLDINGS CORPORATION
0.52%
 1,156,710 0.52% 17,731,450 $
ALFRESA HOLDINGS CORPORATION
0.57%
 1,157,896 0.57% 17,003,691 $
MITSUBISHI UFJ FINANCIAL GROUP, INC
0.01%
 1,547,000 0.01% 15,915,149 $
SUZUKEN CO., LTD.
0.57%
 443,042 0.57% 13,580,044 $
TSUMURA & CO.
0.30%
 229,600 0.30% 5,799,735 $
OHKI HEALTHCARE HOLDINGS CO.,LTD.
3.45%
 486,000 3.45% 3,179,096 $
MY FARM,INC.
11.13%
 300,000 11.13% 2,971,767 $
DAI NIPPON PRINTING CO., LTD.
0.03%
 90,500 0.03% 2,793,125 $
THE SHIGA BANK, LTD.
0.10%
 55,440 0.10% 1,536,693 $

Company contact information

Tsumura & Co.

2-17-11 Akasaka Minato-Ku

107-8521, Tokyo

+

http://www.tsumura.co.jp
address Tsumura & Co.(4540)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Tsumura & Co.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3,755 JPY
Average target price
4,793 JPY
Spread / Average Target
+27.65%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TSUMURA & CO. Stock Tsumura & Co.
+41.35% 1.81B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.85% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.65% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.49% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.55% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.46% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4540 Stock
  4. Company Tsumura & Co.